Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.04 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 39.34.
Market Cap
8.04T
Revenue
4.52T
Profits
204.29B
PE Ratio
39.34
Profit Margin
4.52%
Dividend Yield
0.46%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 793.37B | 0.96% | 3,070,031 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 584.06B | 0.85% | 7,240,866 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 376.96B | 1.78% | 7,539,504 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 300.74B | 2.90% | 2,113,881 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 291.99B | -1.28% | 11,083,599 | 65.01B |
| 6 | NVS | Novartis AG | 285.70B | 1.47% | 2,078,121 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 237.62B | 1.07% | 6,254,623 | 447.57B |
| 8 | AMGN | Amgen Inc. | 188.13B | 0.07% | 1,755,748 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 178.33B | 1.41% | 1,819,422 | 44.56B |
| 10 | ABT | Abbott Laboratories | 177.44B | -2.03% | 10,476,415 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 169.23B | 1.56% | 6,171,226 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 160.81B | 0.03% | 2,195,542 | 10.06B |
| 13 | PFE | Pfizer Inc. | 157.97B | 2.70% | 36,003,330 | 62.58B |
| 14 | NVO | Novo Nordisk A/S | 157.25B | 0.47% | 17,379,917 | 48.59B |
| 15 | DHR | Danaher Corporation | 130.14B | 1.31% | 3,979,215 | 24.57B |
| 16 | SYK | Stryker Corporation | 124.79B | -0.41% | 1,925,275 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 121.95B | 2.03% | 9,697,177 | 48.19B |
| 18 | SNY | Sanofi | 113.27B | -0.13% | 2,382,092 | 54.85B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 112.58B | 2.33% | 1,961,009 | 12.00B |
| 20 | MDT | Medtronic plc | 110.08B | -1.61% | 8,715,301 | 35.48B |
| 21 | GSK | GSK plc | 108.78B | 0.72% | 3,361,451 | 43.97B |
| 22 | MCK | McKesson Corporation | 105.36B | - | 689,180 | 397.96B |
| 23 | HCA | HCA Healthcare, Inc. | 104.59B | -0.85% | 891,196 | 75.60B |
| 24 | BSX | Boston Scientific Corporation | 93.53B | -9.02% | 39,872,260 | 20.07B |
| 25 | CVS | CVS Health Corporation | 89.23B | 0.09% | 7,305,944 | 399.83B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.89B | 1.57% | 630,093 | 14.34B |
| 27 | CI | The Cigna Group | 68.05B | -1.48% | 2,392,771 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 62.56B | -0.56% | 1,038,615 | 199.13B |
| 29 | COR | Cencora, Inc. | 60.29B | -0.81% | 1,163,570 | 325.78B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 56.56B | 2.01% | 3,136,343 | 28.48B |
| 31 | MDLN | Medline Inc. | 55.99B | 3.05% | 7,765,190 | 28.43B |
| 32 | ZTS | Zoetis Inc. | 49.11B | 2.63% | 2,912,584 | 9.47B |
| 33 | CAH | Cardinal Health, Inc. | 48.55B | -0.13% | 1,513,624 | 244.67B |
| 34 | EW | Edwards Lifesciences Corporation | 45.84B | 0.20% | 4,910,887 | 6.07B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.36B | -0.22% | 460,655 | 4.30B |
| 36 | HLN | Haleon plc | 44.26B | 2.04% | 9,512,149 | 14.85B |
| 37 | BDX | Becton, Dickinson and Company | 44.05B | 0.12% | 1,855,826 | 21.92B |
| 38 | ARGX | argenx SE | 43.57B | 1.87% | 307,546 | 4.24B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.92B | -0.40% | 1,223,873 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.18B | 0.45% | 1,276,654 | 10.40B |
| 41 | INSM | Insmed Incorporated | 33.05B | 5.52% | 4,958,472 | 606.42M |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 33.02B | -1.36% | 4,984,553 | 17.26B |
| 43 | RMD | ResMed Inc. | 31.91B | -0.20% | 1,074,629 | 5.40B |
| 44 | A | Agilent Technologies, Inc. | 31.65B | 1.61% | 1,372,919 | 7.07B |
| 45 | ONC | BeOne Medicines AG | 31.50B | 0.37% | 152,576 | 5.34B |
| 46 | GEHC | GE HealthCare Technologies Inc. | 31.38B | -0.66% | 3,775,280 | 20.63B |
| 47 | WAT | Waters Corporation | 28.78B | 1.46% | 786,307 | 3.17B |
| 48 | VEEV | Veeva Systems Inc. | 28.74B | 1.95% | 1,564,483 | 3.20B |
| 49 | IQV | IQVIA Holdings Inc. | 27.89B | 1.41% | 1,281,246 | 16.31B |
| 50 | BIIB | Biogen Inc. | 27.53B | 2.03% | 799,790 | 9.89B |
| 51 | RPRX | Royalty Pharma plc | 26.75B | 0.04% | 2,274,846 | 2.38B |
| 52 | NTRA | Natera, Inc. | 26.48B | 2.29% | 995,138 | 2.31B |
| 53 | UTHR | United Therapeutics Corporation | 25.79B | 12.53% | 1,722,070 | 3.18B |
| 54 | PHG | Koninklijke Philips N.V. | 25.50B | -0.93% | 1,036,541 | 20.94B |
| 55 | MTD | Mettler-Toledo International Inc. | 25.27B | 1.29% | 108,466 | 4.03B |
| 56 | DXCM | DexCom, Inc. | 23.82B | -0.56% | 3,991,122 | 4.66B |
| 57 | LH | Labcorp Holdings Inc. | 21.72B | -0.22% | 690,702 | 13.95B |
| 58 | DGX | Quest Diagnostics Incorporated | 21.66B | 0.84% | 865,566 | 11.04B |
| 59 | STE | STERIS plc | 21.52B | -0.01% | 460,126 | 5.83B |
| 60 | BNTX | BioNTech SE | 20.46B | -0.50% | 583,175 | 3.37B |
| 61 | HUM | Humana Inc. | 19.93B | -1.83% | 1,766,371 | 129.66B |
| 62 | MRNA | Moderna, Inc. | 19.13B | -2.68% | 4,084,326 | 1.94B |
| 63 | ROIV | Roivant Sciences Ltd. | 18.90B | -0.41% | 4,284,879 | 13.31M |
| 64 | ILMN | Illumina, Inc. | 18.47B | 2.67% | 1,053,138 | 4.34B |
| 65 | RVMD | Revolution Medicines, Inc. | 18.37B | 0.22% | 1,747,130 | - |
| 66 | INCY | Incyte Corporation | 17.98B | 0.03% | 1,535,456 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 17.66B | 0.74% | 792,932 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 17.34B | 0.06% | 1,958,714 | 8.23B |
| 69 | HOLX | Hologic, Inc. | 16.87B | -0.16% | 2,855,284 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 16.35B | -2.01% | 955,008 | 21.31B |
| 71 | GMAB | Genmab A/S | 15.88B | 0.04% | 859,279 | 3.72B |
| 72 | CNC | Centene Corporation | 15.64B | -0.62% | 6,142,800 | 176.15B |
| 73 | VTRS | Viatris Inc. | 14.92B | -0.69% | 7,458,291 | 14.30B |
| 74 | PODD | Insulet Corporation | 14.64B | -0.10% | 792,620 | 2.71B |
| 75 | COO | The Cooper Companies, Inc. | 13.52B | -0.66% | 1,760,935 | 4.15B |
| 76 | SNN | Smith & Nephew plc | 13.46B | -0.16% | 531,066 | 6.16B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.45B | -0.49% | 1,554,357 | 502.08M |
| 78 | ASND | Ascendis Pharma A/S | 13.40B | 0.65% | 286,925 | 845.52M |
| 79 | SMMT | Summit Therapeutics Inc. | 13.17B | 2.41% | 2,419,792 | - |
| 80 | MEDP | Medpace Holdings, Inc. | 13.06B | 2.02% | 233,400 | 2.53B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 12.92B | 0.31% | 740,573 | 2.86B |
| 82 | PEN | Penumbra, Inc. | 12.88B | -2.06% | 1,600,843 | 1.40B |
| 83 | FMS | Fresenius Medical Care AG | 12.09B | 0.68% | 329,310 | 23.05B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 11.98B | 0.51% | 2,045,201 | 943.71M |
| 85 | ALGN | Align Technology, Inc. | 11.85B | -0.07% | 1,055,826 | 4.03B |
| 86 | ELAN | Elanco Animal Health Incorporated | 11.65B | 1.34% | 5,257,940 | 4.72B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.59B | -1.05% | 372,685 | 958.40M |
| 88 | ENSG | The Ensign Group, Inc. | 11.56B | -0.12% | 454,997 | 5.06B |
| 89 | RGC | Regencell Bioscience Holdings Limited | 11.54B | -9.12% | 76,668 | - |
| 90 | GH | Guardant Health, Inc. | 11.31B | 1.88% | 2,072,124 | 982.02M |
| 91 | GMED | Globus Medical, Inc. | 11.29B | -0.32% | 915,002 | 2.94B |
| 92 | JAZZ | Jazz Pharmaceuticals plc | 11.27B | 0.25% | 478,842 | 4.27B |
| 93 | UHS | Universal Health Services, Inc. | 11.12B | -1.05% | 601,797 | 17.36B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.06B | -0.15% | 1,678,695 | 3.85B |
| 95 | SOLV | Solventum Corporation | 11.00B | 1.10% | 1,534,777 | 8.33B |
| 96 | EXEL | Exelixis, Inc. | 10.89B | 1.01% | 2,103,763 | 2.32B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.54B | 1.20% | 999,465 | 3.22B |
| 98 | DVA | DaVita Inc. | 10.17B | -1.33% | 623,337 | 13.64B |
| 99 | EHC | Encompass Health Corporation | 9.70B | -0.05% | 867,024 | 5.94B |
| 100 | RVTY | Revvity, Inc. | 9.48B | 1.05% | 1,012,092 | 2.86B |
| 101 | MASI | Masimo Corporation | 9.26B | 0.12% | 1,590,490 | 1.53B |
| 102 | BTSG | BrightSpring Health Services, Inc. | 8.48B | -1.87% | 1,982,128 | 12.91B |
| 103 | HSIC | Henry Schein, Inc. | 8.34B | 0.83% | 941,786 | 13.18B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 8.21B | 2.65% | 517,963 | 638.50M |
| 105 | BAX | Baxter International Inc. | 8.16B | -1.06% | 7,449,810 | 11.24B |
| 106 | TECH | Bio-Techne Corporation | 8.14B | 2.14% | 1,757,539 | 1.22B |
| 107 | QGEN | Qiagen N.V. | 8.10B | 0.64% | 1,236,401 | 2.09B |
| 108 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.07B | -0.22% | 1,464,983 | 1.09B |
| 109 | ABVX | ABIVAX Société Anonyme | 8.05B | -0.95% | 739,324 | 5.37M |
| 110 | ICLR | ICON Public Limited Company | 8.03B | 2.96% | 1,089,566 | 8.10B |
| 111 | PCVX | Vaxcyte, Inc. | 7.91B | 3.39% | 1,124,591 | - |
| 112 | ATR | AptarGroup, Inc. | 7.87B | 1.12% | 343,965 | 3.78B |
| 113 | CRL | Charles River Laboratories International, Inc. | 7.86B | 0.35% | 872,503 | 4.02B |
| 114 | CYTK | Cytokinetics, Incorporated | 7.76B | 0.75% | 2,443,147 | 88.04M |
| 115 | PRAX | Praxis Precision Medicines, Inc. | 7.70B | -4.71% | 533,854 | 7.46M |
| 116 | NUVL | Nuvalent, Inc. | 7.60B | 0.06% | 719,207 | - |
| 117 | TEM | Tempus AI, Inc. | 7.57B | -0.59% | 4,060,632 | 1.27B |
| 118 | HALO | Halozyme Therapeutics, Inc. | 7.36B | 0.81% | 1,109,696 | 1.40B |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 7.30B | 1.87% | 208,564 | 2.58B |
| 120 | KRYS | Krystal Biotech, Inc. | 7.22B | 0.63% | 418,508 | 389.13M |
| 121 | HQY | HealthEquity, Inc. | 6.88B | -1.25% | 1,404,420 | 1.31B |
| 122 | MOH | Molina Healthcare, Inc. | 6.85B | -1.91% | 878,674 | 43.56B |
| 123 | IBRX | ImmunityBio, Inc. | 6.85B | -9.76% | 23,276,424 | 113.29M |
| 124 | ACLX | Arcellx, Inc. | 6.73B | 0.17% | 1,242,352 | 22.29M |
| 125 | KYMR | Kymera Therapeutics, Inc. | 6.49B | 1.69% | 584,733 | 39.21M |
| 126 | PTGX | Protagonist Therapeutics, Inc. | 6.37B | 0.91% | 884,395 | 46.02M |
| 127 | RGEN | Repligen Corporation | 6.28B | 1.24% | 654,540 | 738.26M |
| 128 | GRFS | Grifols, S.A. | 6.25B | 0.93% | 480,804 | 8.83B |
| 129 | GKOS | Glaukos Corporation | 6.10B | 1.77% | 607,792 | 507.44M |
| 130 | TERN | Terns Pharmaceuticals, Inc. | 5.98B | -0.08% | 7,802,786 | - |
| 131 | BLTE | Belite Bio, Inc | 5.87B | -1.90% | 155,808 | - |
| 132 | APGE | Apogee Therapeutics, Inc. | 5.81B | 1.16% | 988,788 | - |
| 133 | COGT | Cogent Biosciences, Inc. | 5.70B | -1.97% | 1,655,268 | - |
| 134 | PTCT | PTC Therapeutics, Inc. | 5.43B | -0.74% | 930,030 | 1.73B |
| 135 | BLCO | Bausch + Lomb Corporation | 5.41B | -0.72% | 576,757 | 5.10B |
| 136 | CGON | CG Oncology, Inc. | 5.40B | -1.02% | 957,756 | 4.04M |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 5.30B | -0.61% | 2,076,145 | 521.31M |
| 138 | XENE | Xenon Pharmaceuticals Inc. | 5.30B | 1.96% | 1,051,598 | 7.50M |
| 139 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.28B | 1.89% | 1,259,801 | 189.76M |
| 140 | CELC | Celcuity Inc. | 5.23B | 2.12% | 553,848 | - |
| 141 | BRKR | Bruker Corporation | 5.22B | 1.75% | 1,367,928 | 3.44B |
| 142 | AVTR | Avantor, Inc. | 5.18B | 2.43% | 7,854,740 | 6.55B |
| 143 | CHE | Chemed Corporation | 5.15B | 1.49% | 342,170 | 2.53B |
| 144 | TFX | Teleflex Incorporated | 5.08B | -1.11% | 652,498 | 1.99B |
| 145 | ALKS | Alkermes plc | 5.01B | 2.59% | 2,518,603 | 1.48B |
| 146 | SRRK | Scholar Rock Holding Corporation | 4.95B | 1.13% | 777,903 | - |
| 147 | IMVT | Immunovant, Inc. | 4.79B | -1.79% | 1,157,494 | - |
| 148 | PACS | PACS Group, Inc. | 4.77B | -0.69% | 1,102,318 | 5.29B |
| 149 | CAI | Caris Life Sciences, Inc. | 4.76B | -0.59% | 2,054,441 | 812.03M |
| 150 | LNTH | Lantheus Holdings, Inc. | 4.75B | -1.85% | 664,937 | 1.54B |
| 151 | TGTX | TG Therapeutics, Inc. | 4.65B | -0.76% | 1,645,239 | 616.29M |
| 152 | ERAS | Erasca, Inc. | 4.64B | -0.20% | 5,229,250 | - |
| 153 | FOLD | Amicus Therapeutics, Inc. | 4.53B | 0.14% | 1,482,289 | 634.21M |
| 154 | WAY | Waystar Holding Corp. | 4.50B | -0.34% | 1,432,554 | 1.10B |
| 155 | DOCS | Doximity, Inc. | 4.38B | 0.17% | 2,109,216 | 637.78M |
| 156 | RDNT | RadNet, Inc. | 4.33B | -0.73% | 682,790 | 2.04B |
| 157 | HIMS | Hims & Hers Health, Inc. | 4.28B | -3.10% | 17,403,972 | 2.35B |
| 158 | CRSP | CRISPR Therapeutics AG | 4.26B | -3.08% | 1,461,266 | 3.51M |
| 159 | OPCH | Option Care Health, Inc. | 4.22B | -0.99% | 1,265,983 | 5.65B |
| 160 | DNTH | Dianthus Therapeutics, Inc. | 4.21B | -2.07% | 962,351 | 2.04M |
| 161 | MMSI | Merit Medical Systems, Inc. | 4.08B | -0.13% | 675,824 | 1.52B |
| 162 | CORT | Corcept Therapeutics Incorporated | 4.05B | 1.38% | 1,956,327 | 761.41M |
| 163 | MMED | Minimed Group, Inc. | 4.03B | -0.83% | 888,581 | 2.89B |
| 164 | CNTA | Centessa Pharmaceuticals plc | 4.03B | -3.90% | 1,689,254 | 15.00M |
| 165 | NVST | Envista Holdings Corporation | 3.98B | -1.38% | 1,579,589 | 2.72B |
| 166 | LGND | Ligand Pharmaceuticals Incorporated | 3.84B | -1.45% | 215,365 | 268.09M |
| 167 | AMRX | Amneal Pharmaceuticals, Inc. | 3.81B | 0.84% | 1,002,523 | 3.02B |
| 168 | SHC | Sotera Health Company | 3.77B | 0.91% | 1,872,608 | 1.16B |
| 169 | IRTC | iRhythm Holdings, Inc. | 3.69B | -3.29% | 812,865 | 747.14M |
| 170 | STVN | Stevanato Group S.p.A. | 3.68B | 0.30% | 442,369 | 1.39B |
| 171 | ACAD | ACADIA Pharmaceuticals Inc. | 3.59B | 1.54% | 1,723,976 | 1.07B |
| 172 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.59B | 1.78% | 1,114,366 | 7.70M |
| 173 | SYRE | Spyre Therapeutics, Inc. | 3.57B | -3.99% | 712,469 | - |
| 174 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.50B | -0.11% | 325,149 | 677.56M |
| 175 | VKTX | Viking Therapeutics, Inc. | 3.46B | -8.00% | 3,189,867 | - |
| 176 | ALHC | Alignment Healthcare, Inc. | 3.44B | 1.38% | 2,951,910 | 3.95B |
| 177 | NAMS | NewAmsterdam Pharma Company N.V. | 3.37B | -2.17% | 504,920 | 22.50M |
| 178 | LIVN | LivaNova PLC | 3.35B | -0.94% | 625,161 | 1.39B |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 3.25B | -1.82% | 614,234 | - |
| 180 | TMDX | TransMedics Group, Inc. | 3.24B | -4.79% | 1,201,755 | 605.49M |
| 181 | OSCR | Oscar Health, Inc. | 3.23B | -2.60% | 7,160,583 | 11.70B |
| 182 | BLLN | BillionToOne, Inc. | 3.22B | 0.81% | 294,876 | 305.11M |
| 183 | LEGN | Legend Biotech Corporation | 3.20B | 3.04% | 1,544,812 | 1.03B |
| 184 | BKD | Brookdale Senior Living Inc. | 3.19B | -3.04% | 3,430,656 | 3.05B |
| 185 | ICUI | ICU Medical, Inc. | 3.13B | 0.96% | 293,284 | 2.23B |
| 186 | GPCR | Structure Therapeutics Inc. | 3.11B | -4.31% | 943,092 | - |
| 187 | LQDA | Liquidia Corporation | 3.10B | 0.43% | 943,592 | 158.32M |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.03B | -2.61% | 171,862 | 803.79M |
| 189 | ITGR | Integer Holdings Corporation | 2.93B | -0.20% | 570,487 | 1.85B |
| 190 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.90B | 1.62% | 802,726 | 588.99M |
| 191 | HNGE | Hinge Health, Inc. | 2.90B | 1.43% | 890,108 | 587.86M |
| 192 | DNLI | Denali Therapeutics Inc. | 2.87B | -0.44% | 1,401,337 | - |
| 193 | TARS | Tarsus Pharmaceuticals, Inc. | 2.85B | 1.01% | 362,293 | 451.36M |
| 194 | SUPN | Supernus Pharmaceuticals, Inc. | 2.84B | -0.34% | 560,681 | 718.95M |
| 195 | DYN | Dyne Therapeutics, Inc. | 2.82B | -0.29% | 1,702,215 | - |
| 196 | PBH | Prestige Consumer Healthcare Inc. | 2.77B | -1.20% | 592,019 | 1.10B |
| 197 | IDYA | IDEAYA Biosciences, Inc. | 2.76B | 3.25% | 649,170 | 218.71M |
| 198 | TNGX | Tango Therapeutics, Inc. | 2.74B | -0.26% | 2,319,191 | 62.38M |
| 199 | VERA | Vera Therapeutics, Inc. | 2.72B | -1.96% | 426,016 | - |
| 200 | CON | Concentra Group Holdings Parent, Inc. | 2.71B | -0.33% | 679,290 | 2.16B |
| 201 | TWST | Twist Bioscience Corporation | 2.65B | -2.85% | 1,091,796 | 391.56M |
| 202 | ARQT | Arcutis Biotherapeutics, Inc. | 2.65B | 0.52% | 1,313,814 | 376.07M |
| 203 | RCUS | Arcus Biosciences, Inc. | 2.59B | 1.82% | 578,674 | 247.00M |
| 204 | ALMS | Alumis Inc. | 2.57B | -18.51% | 5,585,402 | 24.05M |
| 205 | HAE | Haemonetics Corporation | 2.55B | 1.65% | 479,191 | 1.32B |
| 206 | TVTX | Travere Therapeutics, Inc. | 2.55B | 1.50% | 1,031,567 | 490.73M |
| 207 | TXG | 10x Genomics, Inc. | 2.53B | 1.69% | 1,276,342 | 642.82M |
| 208 | NHC | National HealthCare Corporation | 2.52B | 0.84% | 104,449 | 1.52B |
| 209 | WRBY | Warby Parker Inc. | 2.49B | 0.05% | 2,610,224 | 871.91M |
| 210 | PRVA | Privia Health Group, Inc. | 2.48B | - | 798,211 | 2.12B |
| 211 | HCM | HUTCHMED (China) Limited | 2.45B | 1.62% | 176,516 | 548.51M |
| 212 | LMAT | LeMaitre Vascular, Inc. | 2.43B | 0.23% | 305,623 | 249.60M |
| 213 | LFST | LifeStance Health Group, Inc. | 2.43B | -1.27% | 1,268,714 | 1.42B |
| 214 | VCYT | Veracyte, Inc. | 2.42B | 1.43% | 1,326,413 | 517.15M |
| 215 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.37B | 1.29% | 2,013,769 | 874.84M |
| 216 | GRDN | Guardian Pharmacy Services, Inc. | 2.36B | 9.05% | 760,925 | 1.45B |
| 217 | IRON | Disc Medicine, Inc. | 2.32B | 1.15% | 595,690 | - |
| 218 | MANE | Veradermics, Incorporated | 2.27B | -7.14% | 599,549 | - |
| 219 | ORKA | Oruka Therapeutics, Inc. | 2.26B | 2.34% | 827,138 | - |
| 220 | XRAY | DENTSPLY SIRONA Inc. | 2.23B | -2.35% | 4,852,591 | 3.68B |
| 221 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.05% | 1,254,413 | 158.18M |
| 222 | AAPG | Ascentage Pharma Group International | 2.19B | 0.48% | 1,113 | 82.08M |
| 223 | ELVN | Enliven Therapeutics, Inc. | 2.19B | -5.77% | 2,004,290 | - |
| 224 | APLS | Apellis Pharmaceuticals, Inc. | 2.18B | 0.71% | 2,165,368 | 1.00B |
| 225 | IMNM | Immunome, Inc. | 2.18B | -1.58% | 906,545 | 6.94M |
| 226 | ADMA | ADMA Biologics, Inc. | 2.18B | -1.08% | 8,056,033 | 510.17M |
| 227 | BEAM | Beam Therapeutics Inc. | 2.17B | -1.31% | 2,264,377 | 139.74M |
| 228 | PAHC | Phibro Animal Health Corporation | 2.16B | -0.98% | 231,075 | 1.46B |
| 229 | SRPT | Sarepta Therapeutics, Inc. | 2.15B | 2.55% | 2,923,721 | 2.20B |
| 230 | ACHC | Acadia Healthcare Company, Inc. | 2.10B | -0.35% | 2,552,444 | 3.31B |
| 231 | KOD | Kodiak Sciences Inc. | 2.09B | -9.03% | 2,176,773 | - |
| 232 | HTFL | HeartFlow, Inc. | 2.05B | -3.32% | 1,533,998 | 176.03M |
| 233 | SEM | Select Medical Holdings Corporation | 2.02B | - | 1,430,557 | 5.45B |
| 234 | AHG | Akso Health Group | 2.01B | -0.42% | 153,507 | 14.84M |
| 235 | ZLAB | Zai Lab Limited | 2.01B | -0.83% | 383,842 | 460.16M |
| 236 | SNDX | Syndax Pharmaceuticals, Inc. | 1.98B | -4.30% | 1,538,936 | 172.35M |
| 237 | ADPT | Adaptive Biotechnologies Corporation | 1.98B | 3.55% | 1,610,159 | 276.98M |
| 238 | CLDX | Celldex Therapeutics, Inc. | 1.96B | -2.71% | 650,110 | 1.55M |
| 239 | NEOG | Neogen Corporation | 1.94B | 2.41% | 2,060,505 | 880.32M |
| 240 | MLYS | Mineralys Therapeutics, Inc. | 1.94B | -0.72% | 997,792 | - |
| 241 | GRAL | GRAIL, Inc. | 1.92B | -3.28% | 727,873 | 147.17M |
| 242 | GLPG | Galapagos NV | 1.92B | -0.31% | 134,603 | 1.31B |
| 243 | VRDN | Viridian Therapeutics, Inc. | 1.89B | -32.35% | 13,337,294 | 70.85M |
| 244 | RARE | Ultragenyx Pharmaceutical Inc. | 1.89B | -0.41% | 3,655,358 | 673.00M |
| 245 | MESO | Mesoblast Limited | 1.89B | 0.07% | 178,684 | 65.38M |
| 246 | STOK | Stoke Therapeutics, Inc. | 1.88B | -3.29% | 480,049 | 184.42M |
| 247 | NKTR | Nektar Therapeutics | 1.87B | -4.97% | 1,006,963 | 55.23M |
| 248 | BHC | Bausch Health Companies Inc. | 1.86B | 0.20% | 1,801,476 | 10.27B |
| 249 | TYRA | Tyra Biosciences, Inc. | 1.86B | -4.66% | 1,541,051 | - |
| 250 | AUPH | Aurinia Pharmaceuticals Inc. | 1.86B | -2.03% | 1,334,123 | 283.06M |
| 251 | ZYME | Zymeworks Inc. | 1.79B | 0.12% | 596,663 | 105.97M |
| 252 | PHVS | Pharvaris N.V. | 1.77B | -0.33% | 216,183 | - |
| 253 | WGS | GeneDx Holdings Corp. | 1.75B | 4.41% | 1,156,816 | 427.54M |
| 254 | DFTX | Definium Therapeutics, Inc. | 1.74B | -2.13% | 1,615,336 | - |
| 255 | AGIO | Agios Pharmaceuticals, Inc. | 1.73B | 0.61% | 821,013 | 54.03M |
| 256 | ADUS | Addus HomeCare Corporation | 1.71B | -0.85% | 194,439 | 1.42B |
| 257 | INVA | Innoviva, Inc. | 1.70B | 1.10% | 2,035,092 | 411.33M |
| 258 | AORT | Artivion, Inc. | 1.70B | 0.34% | 785,679 | 441.33M |
| 259 | MD | Pediatrix Medical Group, Inc. | 1.69B | 1.46% | 1,063,776 | 1.91B |
| 260 | RLAY | Relay Therapeutics, Inc. | 1.67B | -2.60% | 1,568,291 | 15.36M |
| 261 | ATEC | Alphatec Holdings, Inc. | 1.66B | 0.64% | 2,278,809 | 764.16M |
| 262 | SION | Sionna Therapeutics, Inc. | 1.65B | 1.38% | 344,230 | - |
| 263 | AXGN | Axogen, Inc. | 1.63B | 0.13% | 914,838 | 225.21M |
| 264 | OCUL | Ocular Therapeutix, Inc. | 1.61B | -1.99% | 3,140,861 | 51.95M |
| 265 | ESTA | Establishment Labs Holdings Inc. | 1.60B | -1.12% | 430,967 | 211.08M |
| 266 | CAPR | Capricor Therapeutics, Inc. | 1.60B | -3.91% | 745,372 | 11.13M |
| 267 | ANAB | AnaptysBio, Inc. | 1.59B | -3.50% | 957,179 | 234.60M |
| 268 | SLNO | Soleno Therapeutics, Inc. | 1.57B | 1.30% | 1,393,349 | 190.41M |
| 269 | VCEL | Vericel Corporation | 1.56B | 4.12% | 916,278 | 276.26M |
| 270 | HRMY | Harmony Biosciences Holdings, Inc. | 1.56B | 1.36% | 628,727 | 868.45M |
| 271 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | 1.22% | 185,318 | 883.37M |
| 272 | AHCO | AdaptHealth Corp. | 1.53B | 0.80% | 2,419,032 | 3.24B |
| 273 | NRIX | Nurix Therapeutics, Inc. | 1.52B | -0.61% | 1,036,653 | 83.98M |
| 274 | RXRX | Recursion Pharmaceuticals, Inc. | 1.50B | -3.40% | 15,469,520 | 74.68M |
| 275 | NBTX | Nanobiotix S.A. | 1.50B | 2.10% | 63,352 | 11.93M |
| 276 | SGRY | Surgery Partners, Inc. | 1.49B | 0.96% | 655,778 | 3.31B |
| 277 | PVLA | Palvella Therapeutics, Inc. | 1.49B | -1.52% | 281,730 | - |
| 278 | IMCR | Immunocore Holdings plc | 1.48B | -0.51% | 318,824 | 400.02M |
| 279 | OGN | Organon & Co. | 1.48B | -2.40% | 2,374,369 | 6.22B |
| 280 | OMCL | Omnicell, Inc. | 1.47B | -1.22% | 517,904 | 1.18B |
| 281 | GENB | Generate Biomedicines, Inc. | 1.47B | 0.61% | 227,048 | 31.89M |
| 282 | DMRA | Damora Therapeutics, Inc. | 1.46B | -4.82% | 240,980 | - |
| 283 | SNDA | Sonida Senior Living, Inc. | 1.46B | -1.26% | 465,813 | 336.39M |
| 284 | OCS | Oculis Holding AG | 1.45B | -0.57% | 219,112 | 1.51M |
| 285 | INSP | Inspire Medical Systems, Inc. | 1.45B | 0.56% | 1,058,524 | 911.98M |
| 286 | MAZE | Maze Therapeutics, Inc. | 1.44B | -4.51% | 986,961 | 2.50M |
| 287 | PRCT | PROCEPT BioRobotics Corporation | 1.44B | -3.07% | 977,009 | 308.05M |
| 288 | UFPT | UFP Technologies, Inc. | 1.44B | -1.42% | 208,445 | 602.80M |
| 289 | TRVI | Trevi Therapeutics, Inc. | 1.44B | -1.24% | 962,209 | - |
| 290 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.41B | -5.83% | 993,098 | -665.00K |
| 291 | ATRC | AtriCure, Inc. | 1.41B | -2.15% | 534,948 | 534.53M |
| 292 | PGNY | Progyny, Inc. | 1.39B | -1.74% | 970,298 | 1.29B |
| 293 | NUVB | Nuvation Bio Inc. | 1.39B | -4.71% | 3,241,202 | 62.90M |
| 294 | AVAH | Aveanna Healthcare Holdings Inc. | 1.39B | 1.43% | 959,695 | 2.43B |
| 295 | NTLA | Intellia Therapeutics, Inc. | 1.38B | -5.82% | 3,189,185 | 67.67M |
| 296 | IOVA | Iovance Biotherapeutics, Inc. | 1.37B | -5.41% | 9,934,644 | 263.50M |
| 297 | ARDX | Ardelyx, Inc. | 1.36B | 1.28% | 2,287,890 | 407.32M |
| 298 | VIR | Vir Biotechnology, Inc. | 1.35B | 0.71% | 1,487,822 | 68.56M |
| 299 | TNDM | Tandem Diabetes Care, Inc. | 1.34B | -6.74% | 1,805,120 | 1.01B |
| 300 | PRGO | Perrigo Company plc | 1.34B | 1.99% | 3,049,483 | 4.25B |
| 301 | PLSE | Pulse Biosciences, Inc. | 1.33B | -4.57% | 209,586 | 350.00K |
| 302 | RAPP | Rapport Therapeutics, Inc. | 1.32B | -0.54% | 346,981 | - |
| 303 | NVAX | Novavax, Inc. | 1.32B | -4.26% | 4,152,388 | 1.12B |
| 304 | HCSG | Healthcare Services Group, Inc. | 1.31B | 1.14% | 549,474 | 1.84B |
| 305 | MBX | MBX Biosciences, Inc. | 1.28B | -5.54% | 452,861 | - |
| 306 | SVRA | Savara Inc. | 1.28B | -1.75% | 1,195,244 | - |
| 307 | IMTX | Immatics N.V. | 1.25B | -0.75% | 186,915 | 56.67M |
| 308 | WVE | Wave Life Sciences Ltd. | 1.25B | 4.01% | 6,288,690 | 42.73M |
| 309 | GLUE | Monte Rosa Therapeutics, Inc. | 1.24B | 0.98% | 1,008,045 | 123.67M |
| 310 | ENOV | Enovis Corporation | 1.24B | -0.60% | 818,352 | 2.25B |
| 311 | ATAI | AtaiBeckley Inc. | 1.24B | 1.49% | 2,956,979 | 4.09M |
| 312 | HROW | Harrow, Inc. | 1.24B | -1.57% | 641,838 | 272.30M |
| 313 | BCAX | Bicara Therapeutics Inc. | 1.24B | 3.65% | 971,429 | - |
| 314 | ORIC | ORIC Pharmaceuticals, Inc. | 1.22B | 1.08% | 1,394,997 | - |
| 315 | BHVN | Biohaven Ltd. | 1.22B | -3.35% | 1,621,845 | - |
| 316 | MLTX | MoonLake Immunotherapeutics | 1.21B | -2.25% | 1,269,824 | - |
| 317 | IRMD | IRADIMED CORPORATION | 1.21B | -2.48% | 115,838 | 83.81M |
| 318 | ASTH | Astrana Health, Inc. | 1.20B | 0.62% | 382,320 | 3.18B |
| 319 | ARDT | Ardent Health, Inc. | 1.18B | -3.84% | 218,683 | 6.32B |
| 320 | NVCR | NovoCure Limited | 1.18B | -5.56% | 1,335,087 | 655.35M |
| 321 | OLMA | Olema Pharmaceuticals, Inc. | 1.17B | -1.83% | 990,450 | - |
| 322 | TSHA | Taysha Gene Therapies, Inc. | 1.17B | - | 2,317,049 | 9.77M |
| 323 | PGEN | Precigen, Inc. | 1.15B | -11.44% | 12,388,689 | 9.68M |
| 324 | USPH | U.S. Physical Therapy, Inc. | 1.13B | 0.05% | 120,969 | 773.34M |
| 325 | CRVS | Corvus Pharmaceuticals, Inc. | 1.13B | -4.35% | 1,320,532 | - |
| 326 | DBVT | DBV Technologies S.A. | 1.12B | -2.20% | 201,174 | 5.64M |
| 327 | PHAR | Pharming Group N.V. | 1.11B | -1.84% | 16,686 | 376.13M |
| 328 | NNNN | Anbio Biotechnology | 1.08B | 2.88% | 58,339 | 6.92M |
| 329 | KMTS | Kestra Medical Technologies, Ltd. | 1.07B | -5.81% | 358,806 | 83.72M |
| 330 | INNV | InnovAge Holding Corp. | 1.07B | -0.51% | 296,475 | 915.37M |
| 331 | IVA | Inventiva S.A. | 1.05B | -4.20% | 286,516 | 19.93M |
| 332 | SEPN | Septerna, Inc. | 1.05B | -2.39% | 223,281 | 45.95M |
| 333 | ZBIO | Zenas BioPharma, Inc. | 1.05B | 0.08% | 1,201,550 | 10.00M |
| 334 | PNTG | The Pennant Group, Inc. | 1.04B | 1.01% | 211,322 | 947.71M |
| 335 | QDEL | QuidelOrtho Corporation | 1.04B | 3.25% | 2,557,584 | 2.73B |
| 336 | CNMD | CONMED Corporation | 1.03B | -3.15% | 522,009 | 1.37B |
| 337 | ALVO | Alvotech | 1.03B | 5.79% | 722,548 | 588.90M |
| 338 | COLL | Collegium Pharmaceutical, Inc. | 1.02B | -1.39% | 567,866 | 780.57M |
| 339 | ABCL | AbCellera Biologics Inc. | 994.37M | 0.31% | 2,830,670 | 75.13M |
| 340 | EYPT | EyePoint, Inc. | 988.67M | -5.20% | 792,193 | 31.37M |
| 341 | SSII | SS Innovations International, Inc. | 983.70M | 0.20% | 65,257 | 42.48M |
| 342 | BFLY | Butterfly Network, Inc. | 975.24M | -2.30% | 5,098,631 | 97.61M |
| 343 | XERS | Xeris Biopharma Holdings, Inc. | 965.62M | 3.70% | 2,541,908 | 291.85M |
| 344 | CTMX | CytomX Therapeutics, Inc. | 953.34M | -2.43% | 3,551,177 | 76.20M |
| 345 | PCRX | Pacira BioSciences, Inc. | 942.20M | 1.70% | 549,897 | 726.41M |
| 346 | KALV | KalVista Pharmaceuticals, Inc. | 940.44M | -5.02% | 1,468,143 | 73.62M |
| 347 | NEO | NeoGenomics, Inc. | 934.65M | 0.14% | 1,287,372 | 727.33M |
| 348 | AZTA | Azenta, Inc. | 932.75M | 1.76% | 814,245 | 595.03M |
| 349 | AVBP | ArriVent BioPharma, Inc. | 928.68M | -1.96% | 308,160 | - |
| 350 | CRON | Cronos Group Inc. | 925.60M | -2.40% | 1,002,188 | 146.59M |
| 351 | QURE | uniQure N.V. | 921.06M | -0.27% | 1,135,157 | 16.10M |
| 352 | CMPX | Compass Therapeutics, Inc. | 918.45M | -2.11% | 944,488 | 850.00K |
| 353 | TDOC | Teladoc Health, Inc. | 916.96M | - | 3,294,333 | 2.53B |
| 354 | STAA | STAAR Surgical Company | 908.06M | 2.52% | 1,169,345 | 239.44M |
| 355 | BLFS | BioLife Solutions, Inc. | 907.07M | 1.02% | 531,418 | 96.21M |
| 356 | CERT | Certara, Inc. | 903.91M | -1.22% | 7,188,264 | 418.84M |
| 357 | GERN | Geron Corporation | 903.17M | 0.71% | 15,986,551 | 183.88M |
| 358 | CLOV | Clover Health Investments, Corp. | 902.43M | -1.71% | 4,202,143 | 1.92B |
| 359 | INBX | Inhibrx Biosciences, Inc. | 874.67M | 2.55% | 180,269 | 1.30M |
| 360 | AMPH | Amphastar Pharmaceuticals, Inc. | 872.01M | 1.10% | 410,715 | 719.89M |
| 361 | AKTS | Aktis Oncology, Inc. | 868.72M | 8.89% | 452,258 | 6.50M |
| 362 | EVO | Evotec SE | 867.22M | -2.48% | 166,960 | 887.40M |
| 363 | TALK | Talkspace, Inc. | 865.45M | 0.58% | 5,242,176 | 228.87M |
| 364 | INMD | InMode Ltd. | 849.96M | 0.11% | 1,057,447 | 370.50M |
| 365 | CDNA | CareDx, Inc. | 841.48M | -2.09% | 518,378 | 379.81M |
| 366 | ABUS | Arbutus Biopharma Corporation | 840.56M | 0.23% | 915,296 | 14.08M |
| 367 | OPK | OPKO Health, Inc. | 834.97M | -1.79% | 2,681,397 | 606.88M |
| 368 | XNCR | Xencor, Inc. | 832.39M | -0.61% | 938,483 | 125.58M |
| 369 | PHAT | Phathom Pharmaceuticals, Inc. | 829.75M | -0.47% | 1,336,523 | 175.11M |
| 370 | FTRE | Fortrea Holdings Inc. | 829.35M | -2.21% | 1,143,523 | 2.72B |
| 371 | URGN | UroGen Pharma Ltd. | 827.60M | -0.99% | 1,059,318 | 109.79M |
| 372 | MPLT | MapLight Therapeutics, Inc. | 823.69M | 0.86% | 241,510 | - |
| 373 | SDGR | Schrödinger, Inc. | 817.24M | -0.09% | 749,190 | 255.87M |
| 374 | CGEM | Cullinan Therapeutics, Inc. | 812.26M | 4.44% | 658,912 | - |
| 375 | GHRS | GH Research PLC | 808.24M | -0.91% | 114,369 | - |
| 376 | JANX | Janux Therapeutics, Inc. | 792.64M | -1.14% | 840,241 | 10.00M |
| 377 | EVMN | Evommune, Inc. | 792.40M | -0.81% | 133,151 | 13.00M |
| 378 | TBPH | Theravance Biopharma, Inc. | 785.78M | 1.19% | 570,336 | 107.46M |
| 379 | SGP | SpyGlass Pharma, Inc. | 778.63M | 3.36% | 67,792 | - |
| 380 | SPRY | ARS Pharmaceuticals, Inc. | 776.01M | -3.16% | 1,075,240 | 84.28M |
| 381 | LMRI | Lumexa Imaging Holdings, Inc. | 766.00M | 2.31% | 1,103,052 | 1.02B |
| 382 | BVS | Bioventus Inc. | 745.07M | 0.22% | 439,032 | 568.09M |
| 383 | MRVI | Maravai LifeSciences Holdings, Inc. | 740.35M | 0.70% | 823,862 | 185.74M |
| 384 | ANNX | Annexon, Inc. | 739.32M | -0.80% | 2,293,853 | - |
| 385 | MNKD | MannKind Corporation | 730.20M | 3.95% | 4,789,921 | 348.97M |
| 386 | AMN | AMN Healthcare Services, Inc. | 724.03M | -0.95% | 602,710 | 2.73B |
| 387 | SLS | SELLAS Life Sciences Group, Inc. | 719.23M | -8.25% | 8,280,938 | - |
| 388 | SANA | Sana Biotechnology, Inc. | 715.20M | -3.25% | 3,021,375 | - |
| 389 | EHAB | Enhabit, Inc. | 712.66M | 2.86% | 3,560,265 | 1.06B |
| 390 | IART | Integra LifeSciences Holdings Corporation | 710.79M | -0.87% | 707,734 | 1.64B |
| 391 | OMDA | Omada Health, Inc. | 709.76M | 1.60% | 835,021 | 260.21M |
| 392 | TENX | Tenax Therapeutics, Inc. | 704.71M | -5.97% | 253,851 | - |
| 393 | BIOA | BioAge Labs, Inc. | 702.53M | -1.98% | 844,377 | 9.00M |
| 394 | CSTL | Castle Biosciences, Inc. | 700.17M | 0.08% | 286,324 | 344.23M |
| 395 | TLRY | Tilray Brands, Inc. | 697.88M | -5.22% | 2,666,016 | 837.32M |
| 396 | OMER | Omeros Corporation | 695.53M | -0.71% | 1,081,755 | - |
| 397 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 694.68M | -2.25% | 122,561 | - |
| 398 | PHR | Phreesia, Inc. | 687.87M | 3.92% | 2,276,969 | 480.59M |
| 399 | DRUG | Bright Minds Biosciences Inc. | 685.13M | -2.35% | 178,244 | - |
| 400 | KURA | Kura Oncology, Inc. | 682.79M | -0.13% | 1,207,343 | 67.48M |
| 401 | CMPS | COMPASS Pathways plc | 675.56M | -2.42% | 1,157,450 | - |
| 402 | ESPR | Esperion Therapeutics, Inc. | 675.41M | -4.01% | 5,946,451 | 403.14M |
| 403 | RLMD | Relmada Therapeutics, Inc. | 669.20M | -0.78% | 750,543 | - |
| 404 | CBLL | CeriBell, Inc. | 668.51M | -0.06% | 312,117 | 89.06M |
| 405 | MGTX | MeiraGTx Holdings plc | 658.90M | 6.17% | 1,262,348 | 81.39M |
| 406 | GDRX | GoodRx Holdings, Inc. | 654.32M | -1.55% | 1,030,890 | 796.85M |
| 407 | JBIO | Jade Biosciences, Inc. | 653.93M | -0.97% | 242,824 | - |
| 408 | PSNL | Personalis, Inc. | 652.90M | -1.58% | 1,377,712 | 69.65M |
| 409 | ARVN | Arvinas, Inc. | 651.12M | 0.79% | 633,165 | 262.60M |
| 410 | LXRX | Lexicon Pharmaceuticals, Inc. | 639.76M | -8.48% | 3,358,250 | 49.80M |
| 411 | DSGN | Design Therapeutics, Inc. | 639.54M | -1.52% | 183,373 | - |
| 412 | SLDB | Solid Biosciences Inc. | 638.56M | -8.72% | 1,242,294 | - |
| 413 | AVNS | Avanos Medical, Inc. | 638.55M | 1.55% | 398,084 | 701.20M |
| 414 | ANRO | Alto Neuroscience, Inc. | 638.27M | -2.54% | 174,754 | - |
| 415 | NUTX | Nutex Health Inc. | 633.42M | -3.10% | 182,187 | 875.26M |
| 416 | GYRE | Gyre Therapeutics, Inc. | 624.59M | 0.88% | 104,347 | 116.59M |
| 417 | HSTM | HealthStream, Inc. | 619.13M | -0.05% | 212,183 | 304.06M |
| 418 | ETON | Eton Pharmaceuticals, Inc. | 616.08M | -2.84% | 376,934 | 79.95M |
| 419 | VOR | Vor Biopharma Inc. | 610.34M | 1.52% | 1,073,634 | - |
| 420 | REPL | Replimune Group, Inc. | 594.52M | -0.28% | 1,348,007 | - |
| 421 | OCGN | Ocugen, Inc. | 591.32M | -6.42% | 6,876,692 | 4.41M |
| 422 | TCMD | Tactile Systems Technology, Inc. | 588.78M | -1.73% | 191,625 | 329.52M |
| 423 | LBRX | LB Pharmaceuticals Inc | 588.20M | -2.47% | 108,767 | - |
| 424 | DRTS | Alpha Tau Medical Ltd. | 576.46M | -4.52% | 243,224 | - |
| 425 | MDXG | MiMedx Group, Inc. | 573.47M | 1.31% | 923,682 | 418.63M |
| 426 | YDES | YD Bio Limited | 569.59M | 3.71% | 25,856 | 510.36K |
| 427 | PRME | Prime Medicine, Inc. | 557.80M | -6.80% | 3,919,405 | 4.63M |
| 428 | VALN | Valneva SE | 556.03M | 1.05% | 149,864 | 205.07M |
| 429 | CTKB | Cytek Biosciences, Inc. | 552.77M | -0.46% | 640,270 | 201.49M |
| 430 | CBIO | Crescent Biopharma, Inc. | 552.01M | 9.63% | 275,016 | 10.84M |
| 431 | SIBN | SI-BONE, Inc. | 542.35M | -0.08% | 470,865 | 200.93M |
| 432 | TECX | Tectonic Therapeutic, Inc. | 542.08M | -1.64% | 230,124 | - |
| 433 | ALLO | Allogene Therapeutics, Inc. | 541.19M | -1.77% | 4,555,889 | 22.00K |
| 434 | ZURA | Zura Bio Limited | 538.92M | -4.22% | 596,529 | - |
| 435 | IRWD | Ironwood Pharmaceuticals, Inc. | 526.68M | 5.56% | 1,916,215 | 296.15M |
| 436 | EMBC | Embecta Corp. | 523.50M | 3.15% | 1,009,505 | 1.08B |
| 437 | EIKN | Eikon Therapeutics, Inc. | 522.57M | -1.33% | 299,387 | - |
| 438 | BWAY | BrainsWay Ltd. | 519.93M | -0.85% | 161,081 | 52.23M |
| 439 | CRMD | CorMedix Inc. | 519.36M | -2.09% | 1,340,718 | 311.71M |
| 440 | ZVRA | Zevra Therapeutics, Inc. | 515.49M | -4.15% | 671,597 | 106.47M |
| 441 | AVR | Anteris Technologies Global Corp. | 512.83M | -1.54% | 1,029,225 | 1.91M |
| 442 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 6.22M |
| 443 | PRTA | Prothena Corporation plc | 497.96M | -0.11% | 416,146 | 9.68M |
| 444 | AQST | Aquestive Therapeutics, Inc. | 493.06M | 0.50% | 2,423,767 | 44.55M |
| 445 | PROK | ProKidney Corp. | 489.10M | 1.25% | 935,943 | 893.00K |
| 446 | FLGT | Fulgent Genetics, Inc. | 488.13M | 0.26% | 350,774 | 322.67M |
| 447 | ACRS | Aclaris Therapeutics, Inc. | 485.09M | -0.85% | 1,519,891 | 7.83M |
| 448 | AGMB | AgomAb Therapeutics NV | 480.54M | -9.12% | 117,583 | - |
| 449 | UPB | Upstream Bio, Inc. | 477.81M | 1.27% | 863,154 | 2.85M |
| 450 | RIGL | Rigel Pharmaceuticals, Inc. | 475.13M | -0.35% | 228,863 | 294.28M |
| 451 | FBRX | Forte Biosciences, Inc. | 469.32M | 3.22% | 439,892 | - |
| 452 | CTNM | Contineum Therapeutics, Inc. | 465.21M | -6.60% | 190,100 | - |
| 453 | KMDA | Kamada Ltd. | 464.06M | -1.23% | 66,799 | 180.46M |
| 454 | ADCT | ADC Therapeutics SA | 462.44M | -1.62% | 597,441 | 81.36M |
| 455 | KYTX | Kyverna Therapeutics, Inc. | 458.25M | -2.82% | 716,173 | - |
| 456 | VTVT | vTv Therapeutics Inc. | 455.43M | -4.70% | 29,268 | 17.00K |
| 457 | IMMX | Immix Biopharma, Inc. | 454.44M | 5.28% | 912,319 | - |
| 458 | OFIX | Orthofix Medical Inc. | 454.43M | -1.57% | 207,059 | 822.31M |
| 459 | LYEL | Lyell Immunopharma, Inc. | 449.59M | -1.93% | 53,145 | 36.00K |
| 460 | ANGO | AngioDynamics, Inc. | 448.03M | -0.28% | 382,029 | 307.31M |
| 461 | LRMR | Larimar Therapeutics, Inc. | 447.74M | -6.71% | 1,008,341 | - |
| 462 | FULC | Fulcrum Therapeutics, Inc. | 438.23M | -2.23% | 559,461 | 80.00M |
| 463 | BBNX | Beta Bionics, Inc. | 437.61M | -8.36% | 1,628,914 | 100.25M |
| 464 | FDMT | 4D Molecular Therapeutics, Inc. | 437.51M | -8.15% | 1,176,003 | 85.21M |
| 465 | CATX | Perspective Therapeutics, Inc. | 436.37M | -5.90% | 816,072 | 884.00K |
| 466 | NAUT | Nautilus Biotechnology, Inc. | 434.12M | -1.44% | 289,854 | - |
| 467 | VREX | Varex Imaging Corporation | 433.45M | -3.63% | 222,591 | 854.40M |
| 468 | NPCE | NeuroPace, Inc. | 432.28M | -3.68% | 241,630 | 99.99M |
| 469 | STTK | Shattuck Labs, Inc. | 426.52M | -1.00% | 288,773 | 1.00M |
| 470 | VSTM | Verastem, Inc. | 426.00M | -3.77% | 2,318,929 | 30.91M |
| 471 | TRDA | Entrada Therapeutics, Inc. | 423.72M | -1.34% | 243,595 | 25.42M |
| 472 | ASMB | Assembly Biosciences, Inc. | 422.58M | -3.83% | 72,596 | 72.30M |
| 473 | ABSI | Absci Corporation | 422.34M | -0.72% | 3,563,020 | 2.80M |
| 474 | EBS | Emergent BioSolutions Inc. | 415.74M | 1.51% | 720,615 | 742.90M |
| 475 | ENGN | enGene Holdings Inc. | 413.99M | -2.98% | 140,079 | - |
| 476 | EPRX | Eupraxia Pharmaceuticals Inc. | 410.80M | -1.64% | 86,785 | - |
| 477 | MYGN | Myriad Genetics, Inc. | 407.70M | 1.87% | 1,368,908 | 824.50M |
| 478 | AVIR | Atea Pharmaceuticals, Inc. | 404.73M | -0.78% | 304,147 | - |
| 479 | RGNX | REGENXBIO Inc. | 401.03M | 0.13% | 619,998 | 170.44M |
| 480 | STRO | Sutro Biopharma, Inc. | 399.27M | -1.35% | 73,433 | 102.48M |
| 481 | AURA | Aura Biosciences, Inc. | 393.72M | -1.12% | 295,020 | - |
| 482 | VNDA | Vanda Pharmaceuticals Inc. | 393.07M | -3.76% | 1,166,134 | 216.11M |
| 483 | AUNA | Auna S.A. | 390.79M | -6.55% | 291,710 | 1.30B |
| 484 | NRC | National Research Corporation | 389.87M | 0.06% | 65,509 | 137.39M |
| 485 | LXEO | Lexeo Therapeutics, Inc. | 384.64M | -3.48% | 828,099 | - |
| 486 | KIDS | OrthoPediatrics Corp. | 384.24M | -2.06% | 173,044 | 236.35M |
| 487 | CYH | Community Health Systems, Inc. | 384.19M | 0.35% | 1,510,829 | 12.49B |
| 488 | PACB | Pacific Biosciences of California, Inc. | 380.52M | - | 9,082,320 | 160.01M |
| 489 | SIGA | SIGA Technologies, Inc. | 376.85M | -0.75% | 622,952 | 94.57M |
| 490 | ALT | Altimmune, Inc. | 374.70M | -4.64% | 3,116,108 | 41.00K |
| 491 | RCKT | Rocket Pharmaceuticals, Inc. | 374.02M | -8.62% | 9,514,141 | - |
| 492 | LCTX | Lineage Cell Therapeutics, Inc. | 366.16M | -1.34% | 882,461 | 14.56M |
| 493 | IPSC | Century Therapeutics, Inc. | 364.84M | 0.50% | 1,408,247 | 109.16M |
| 494 | XFOR | X4 Pharmaceuticals, Inc. | 362.77M | -1.24% | 358,508 | 35.11M |
| 495 | VMD | Viemed Healthcare, Inc. | 360.93M | 1.08% | 231,957 | 270.28M |
| 496 | XOMA | XOMA Royalty Corporation | 359.91M | 0.20% | 76,543 | 52.15M |
| 497 | LAB | Standard BioTools Inc. | 359.49M | 2.71% | 1,444,964 | 85.33M |
| 498 | CV | CapsoVision, Inc. | 356.84M | -4.66% | 195,837 | 13.55M |
| 499 | MNPR | Monopar Therapeutics Inc. | 356.11M | -1.50% | 113,411 | - |
| 500 | DMAC | DiaMedica Therapeutics Inc. | 355.76M | -2.21% | 343,857 | - |